VRTX:NGS-Vertex Pharmaceuticals Incorporated

EQUITY | Biotechnology | Nasdaq Global Select

Last Closing

USD 177.94

Change

+4.16 (+2.39)%

Market Cap

USD 21.38B

Volume

1.52M

Analyst Target

USD 207.30
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-18 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

+2.75 (+0.29%)

USD 106.98B
MRNA Moderna Inc

+3.18 (+2.96%)

USD 39.68B
ARGX argenx NV ADR

+1.02 (+0.26%)

USD 23.67B
BNTX BioNTech SE

+1.27 (+1.38%)

USD 22.34B
GMAB Genmab AS

-0.20 (-0.65%)

USD 19.78B
ALNY Alnylam Pharmaceuticals Inc

+2.42 (+1.59%)

USD 19.08B
RPRX Royalty Pharma Plc

+0.22 (+0.73%)

USD 18.18B
BGNE BeiGene Ltd

+1.27 (+0.83%)

USD 16.99B
BMRN Biomarin Pharmaceutical Inc

+0.87 (+0.99%)

USD 16.06B
INCY Incyte Corporation

+0.57 (+1.01%)

USD 12.79B

ETFs Containing VRTX

DCCHAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

-0.31 (0.31%)

USD 0.06B
DCUSAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

-0.41 (0.31%)

USD 0.06B
DCEUAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

-0.24 (0.31%)

USD 0.02B
DCGBAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

-0.31 (0.31%)

USD 1.88M
BBH VanEck Biotech ETF 9.38 % 0.35 %

+1.88 (+0.31%)

USD 0.45B
CURE:XETRA VanEck Genomics and Healt.. 9.09 % 0.00 %

+0.14 (+0.31%)

USD 7.01M
BTEC:SW iShares Nasdaq US Biotech.. 8.73 % 0.00 %

+0.01 (+0.31%)

USD 0.45B
MSGR 8.22 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 7.96 % 0.47 %

+1.92 (+0.31%)

USD 7.79B
BIS ProShares UltraShort Nasd.. 7.21 % 0.95 %

-0.50 (0.31%)

USD 3.90M
UBIO 6.52 % 0.95 %

N/A

N/A
BIB ProShares Ultra Nasdaq Bi.. 5.80 % 0.95 %

+1.78 (+0.31%)

USD 0.10B
XGEN:XETRA Xtrackers MSCI Genomic He.. 5.19 % 0.00 %

+0.25 (+0.31%)

USD 3.60M
XNNV:XETRA Xtrackers MSCI Innovation.. 5.18 % 0.00 %

-0.15 (0.31%)

USD 7.58M
XDG3:XETRA Xtrackers MSCI Global SDG.. 5.03 % 0.00 %

+0.32 (+0.31%)

USD 0.15B
LIFE-U:CA Evolve Global Healthcare .. 5.00 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.97 % 0.00 %

+0.13 (+0.31%)

USD 3.60M
PBE Invesco Dynamic Biotechno.. 4.81 % 0.57 %

+0.63 (+0.31%)

USD 0.24B
XNNS:LSE Xtrackers MSCI Innovation.. 4.47 % 0.00 %

-0.17 (0.31%)

USD 7.58M
XNNV:LSE Xtrackers MSCI Innovation.. 4.47 % 0.00 %

-0.21 (0.31%)

USD 7.58M
BIOT:SW L&G Pharma Breakthrough U.. 4.21 % 0.00 %

+0.10 (+0.31%)

N/A
DIP ETF Series Solutions 4.03 % 0.00 %

+0.43 (+0.31%)

USD 1.04M
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.93 % 0.00 %

+0.15 (+0.31%)

USD 0.01B
HEAL:CA 3.39 % 0.00 %

N/A

N/A
CACG ClearBridge All Cap Growt.. 3.02 % 0.53 %

+0.08 (+0.31%)

USD 0.13B
CDNA:CA CI Bio-Revolution ETF 2.89 % 0.00 %

N/A

CAD 5.34M
SPME:SW iShares Edge S&P 500 Mini.. 2.55 % 0.00 %

+0.02 (+0.31%)

USD 0.05B
SPLV:SW iShares Edge S&P 500 Mini.. 2.55 % 0.00 %

+0.41 (+0.31%)

USD 1.95B
SPMV 2.46 % 0.00 %

N/A

N/A
UPWD 2.43 % 0.00 %

N/A

N/A
HLTH:AU VanEck Global Healthcare .. 2.38 % 0.00 %

+0.03 (+0.31%)

USD 0.06B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.35 % 0.00 %

+0.06 (+0.31%)

USD 0.05B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.35 % 0.00 %

+0.04 (+0.31%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.35 % 0.00 %

+0.02 (+0.31%)

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.84 % 0.39 %

+1.01 (+0.31%)

CAD 0.32B
RSPH Invesco S&P 500® Equal.. 1.79 % 0.00 %

+0.50 (+0.31%)

USD 0.98B
MVEA:SW iShares Edge MSCI USA Min.. 1.74 % 0.00 %

+0.04 (+0.31%)

USD 0.35B
ESMV iShares ESG MSCI USA Min .. 1.66 % 0.00 %

+0.27 (+0.31%)

USD 0.01B
CURE:AU ETFS S&P Biotech ETF 1.49 % 0.00 %

+0.14 (+0.31%)

USD 0.04B
XWEB:XETRA Xtrackers MSCI World Mini.. 1.48 % 0.00 %

+0.11 (+0.31%)

N/A
MVEC:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

+0.02 (+0.31%)

USD 0.15B
MVEW:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

+0.06 (+0.31%)

USD 0.65B
MVWE:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

+0.03 (+0.31%)

USD 0.07B
MVEW:LSE iShares Edge MSCI World M.. 1.42 % 0.00 %

+0.03 (+0.31%)

USD 0.65B
FLXU:SW Franklin U.S. Equity UCIT.. 1.16 % 0.00 %

N/A

USD 0.16B
THNZ:XETRA L&G Global Thematic ESG E.. 0.86 % 0.00 %

+0.02 (+0.31%)

USD 4.32M
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.64 % 0.00 %

+0.09 (+0.31%)

USD 1.06B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.41 % 0.00 %

+0.28 (+0.31%)

USD 0.54B
JPLG:LSE JPM Global Equity Multi-F.. 0.35 % 0.00 %

+8.25 (+0.31%)

USD 0.10B
JPGL:SW JPM Global Equity Multi-F.. 0.35 % 0.00 %

N/A

N/A
DEF 0.00 % 0.59 %

N/A

N/A
FTLS First Trust Long/Short Eq.. 0.00 % 1.59 %

-0.01 (0.31%)

USD 1.04B
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

-0.53 (0.31%)

USD 0.19B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.42 (+0.31%)

USD 0.02B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.07 (+0.31%)

USD 0.45B
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.05 (+0.31%)

USD 0.49B
BIGT:LSE L&G Pharma Breakthrough U.. 0.00 % 0.00 %

+6.95 (+0.31%)

USD 0.03B
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.06 (+0.31%)

USD 0.49B
VLQ:CA 0.00 % 0.40 %

N/A

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
MVUS:LSE iShares VI Public Limited.. 0.00 % 0.00 %

+1.50 (+0.31%)

USD 1.93B
SMRG:LSE 0.00 % 0.00 %

N/A

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+1.06 (+0.31%)

USD 3.19M
SPMD:LSE iShares Edge S&P 500 Mini.. 0.00 % 0.00 %

+0.01 (+0.31%)

USD 0.10B
SPMV:LSE iShares Edge S&P 500 Mini.. 0.00 % 0.00 %

+0.13 (+0.31%)

USD 1.93B
VMOM:LSE 0.00 % 0.00 %

N/A

N/A
SMRT:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.03B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

+0.06 (+0.31%)

USD 0.49B
ETLI:F Legal & General UCITS ETF.. 0.00 % 0.00 %

+0.10 (+0.31%)

USD 0.03B
FLXU:F Franklin LibertyShares IC.. 0.00 % 0.00 %

+0.32 (+0.31%)

USD 0.15B
IBCK:F iShares VI Public Limited.. 0.00 % 0.00 %

+0.34 (+0.31%)

N/A
IS31:F iShares VI Public Limited.. 0.00 % 0.00 %

+0.03 (+0.31%)

N/A
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

+2.80 (+0.31%)

N/A
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.07 (+0.31%)

USD 0.49B
ETLI:XETRA L&G Pharma Breakthrough U.. 0.00 % 0.00 %

+0.09 (+0.31%)

USD 0.03B
FLXU:XETRA Franklin LibertyShares IC.. 0.00 % 0.00 %

+0.22 (+0.31%)

USD 0.15B
IBCK:XETRA iShares Edge S&P 500 Mini.. 0.00 % 0.00 %

+0.21 (+0.31%)

USD 1.49B
IS31:XETRA iShares Edge S&P 500 Mini.. 0.00 % 0.00 %

+0.02 (+0.31%)

USD 0.11B
SM8T:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.80 (+0.31%)

USD 0.04B
TGGR:CA TD Active Global Equity G.. 0.00 % 0.00 %

N/A

CAD 0.02B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
JPGL:XETRA JPM Global Equity Multi-F.. 0.00 % 0.00 %

+0.12 (+0.31%)

USD 0.16B
MVEA:XETRA iShares Edge MSCI USA Min.. 0.00 % 0.00 %

+0.04 (+0.31%)

USD 0.59B
MVEW:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.03 (+0.31%)

USD 0.78B
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

+0.17 (+0.31%)

USD 0.08B
FLXU:LSE Franklin LibertyQ U.S. Eq.. 0.00 % 0.00 %

+0.14 (+0.31%)

USD 0.15B
NVQ 0.00 % 0.00 %

N/A

N/A
FRUE:LSE Franklin LibertyQ U.S. Eq.. 0.00 % 0.00 %

+0.17 (+0.31%)

USD 0.15B
JPGL:LSE JPM Global Equity Multi-F.. 0.00 % 0.00 %

+0.10 (+0.31%)

USD 0.16B
SMRU:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.10 (+0.31%)

USD 3.20M
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

+0.34 (+0.31%)

USD 0.03B
JPGL:F JPmorgan ETFs Ireland Ica.. 0.00 % 0.00 %

+0.19 (+0.31%)

USD 0.16B
XMLH:F Legal & General Ucits Etf.. 0.00 % 0.00 %

+0.10 (+0.31%)

USD 0.08B
DOCT:SW L&G Healthcare Breakthrou.. 0.00 % 0.00 %

+0.18 (+0.31%)

USD 0.08B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.38% 51% F 48% F
Dividend Return N/A N/A N/A N/A F
Total Return 7.38% 51% F 45% F
Trailing 12 Months  
Capital Gain 17.31% 85% B 86% B+
Dividend Return N/A N/A N/A N/A F
Total Return 17.31% 85% B 85% B
Trailing 5 Years  
Capital Gain 173.42% 86% B+ 90% A-
Dividend Return N/A N/A N/A N/A F
Total Return 173.42% 86% B+ 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 18.54% 71% C- 77% C+
Dividend Return 18.54% 71% C- 75% C
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 37.87% 56% F 31% F
Risk Adjusted Return 48.96% 86% B+ 62% D
Market Capitalization 21.38B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Biotechnology) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.59 3% 22%
Price/Book Ratio 15.62 7% 6%
Price / Cash Flow Ratio 9.23 3% 8%
Price/Free Cash Flow Ratio 38.60 3% 11%
Management Effectiveness  
Return on Equity 67.49% 93% 95%
Return on Invested Capital 21.37% 92% 87%
Return on Assets 43.79% 99% 99%
Debt to Equity Ratio 20.00% 40% 67%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.